Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (381-390 of 628) with videos related to

Pageof 63
Sort By:
Scientific Reports|January 15, 2014
Mesoscale origin of the enhanced cycling-stability of the Si-conductive polymer anode for Li-ion batteriesMeng Gu, Xing-Cheng Xiao, Gao Liu, et al.
Cancers|September 9, 2022
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic ChallengesHassan Awada, Moaath K Mustafa Ali, Bicky Thapa, et al.
Nano Letters|August 20, 2015
In Situ Mass Spectrometric Determination of Molecular Structural Evolution at the Solid Electrolyte Interphase in Lithium-Ion BatteriesZihua Zhu, Yufan Zhou, Pengfei Yan, et al.
Leukemia & Lymphoma|October 23, 2013
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Vu H Duong, Theodore S Gourdin, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Leukemia & Lymphoma|November 3, 2005
Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literatureA Pawarode, M R Baer, S Padmanabhan, et al.
Leukemia Research|December 26, 2008
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemiaJeffrey E Lancet, Maria R Baer, George E Duran, et al.
Cancer Genetics|December 3, 2014
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplicationTheodore S Gourdin, Ying Zou, Yi Ning, et al.
Journal of Clinical Medicine|February 22, 2020
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid LeukemiaCiera L Patzke, Alison P Duffy, Vu H Duong, et al.
Frontiers in Oncology|January 10, 2022
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic TargetNoa G Holtzman, Michael S Lebowitz, Rima Koka, et al.
Pageof 63

Showing results (381-390 of 628) with videos related to

Sort By:
Pageof 63
Scientific Reports|January 15, 2014
Mesoscale origin of the enhanced cycling-stability of the Si-conductive polymer anode for Li-ion batteriesMeng Gu, Xing-Cheng Xiao, Gao Liu, et al.
Cancers|September 9, 2022
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic ChallengesHassan Awada, Moaath K Mustafa Ali, Bicky Thapa, et al.
Nano Letters|August 20, 2015
In Situ Mass Spectrometric Determination of Molecular Structural Evolution at the Solid Electrolyte Interphase in Lithium-Ion BatteriesZihua Zhu, Yufan Zhou, Pengfei Yan, et al.
Leukemia & Lymphoma|October 23, 2013
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Vu H Duong, Theodore S Gourdin, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Leukemia & Lymphoma|November 3, 2005
Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literatureA Pawarode, M R Baer, S Padmanabhan, et al.
Leukemia Research|December 26, 2008
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemiaJeffrey E Lancet, Maria R Baer, George E Duran, et al.
Cancer Genetics|December 3, 2014
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplicationTheodore S Gourdin, Ying Zou, Yi Ning, et al.
Journal of Clinical Medicine|February 22, 2020
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid LeukemiaCiera L Patzke, Alison P Duffy, Vu H Duong, et al.
Frontiers in Oncology|January 10, 2022
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic TargetNoa G Holtzman, Michael S Lebowitz, Rima Koka, et al.
Pageof 63